Yaqin Zhang

Title: Yaqin Zhang: Innovator in Adipose Tissue-Targeting Drug Delivery

Introduction

Yaqin Zhang is a prominent inventor based in Nanjing, China. He has made significant contributions to the field of drug delivery systems, particularly in targeting adipose tissue for obesity treatment. His innovative approach combines biocompatibility with effective drug delivery mechanisms.

Latest Patents

Yaqin Zhang holds a patent for an "Adipose tissue-targeting polypeptide-verbascoside-nanogold particle derivative, preparation method and application thereof." This patent outlines a method for preparing a derivative that enhances drug delivery to adipocytes, thereby improving the efficacy of anti-obesity treatments. The method involves activating a carboxyl group of a cysteine residue, esterifying it with sodium phenolate, and reacting it with PEG-modified nanogold particles. The resulting derivative demonstrates good biocompatibility and significantly enhances the targeted anti-obesity activity of the drug.

Career Highlights

Throughout his career, Yaqin Zhang has worked at notable institutions, including the Affiliated Stomatological Hospital of Nanjing Medical University and Nanjing Medical University. His work has focused on developing innovative solutions for drug delivery and obesity treatment.

Collaborations

Yaqin Zhang has collaborated with esteemed colleagues such as Yi Yuan and Hongwei Li. Their combined expertise has contributed to advancements in the field of drug delivery systems.

Conclusion

Yaqin Zhang's innovative work in adipose tissue-targeting drug delivery represents a significant advancement in obesity treatment. His contributions continue to influence the field and pave the way for future research and development.